Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3.
N Engl J Med. 2023.
PMID: 37921461
Clinical Trial.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators.
Heerspink HJL, et al.
Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1.
Lancet. 2023.
PMID: 37015244
Clinical Trial.
Item in Clipboard
Association between ultrapocessed food and chronic kidney disease.
Lou Arnal LM, Vercet Tormo A, Caverní Muñoz A, Medrano Villarroya C, Lou Calvo E, Munguía Navarro P, Sanz París A.
Lou Arnal LM, et al. Among authors: medrano villarroya c.
Nefrologia (Engl Ed). 2021 Sep-Oct;41(5):489-501. doi: 10.1016/j.nefroe.2021.11.013. Epub 2021 Dec 10.
Nefrologia (Engl Ed). 2021.
PMID: 36165132
Free article.
Review.
Item in Clipboard
Cite
Cite